focus -WSS

focus

author：entertainment 2025-09-02 11:47:08 - browse：16982

The home health industry lobbying group is suing Medicare over new payment cuts. But profits in the sector remain near all-time highs. Business Insider/AP

The National Association of Home Care and Hospice sued the Biden administration to halt the government’s recent proposed rule that would cut Medicare payments to home health agencies by 2.2% in 2024.

Since 2020, Medicare has updated its system for how it pays for home health, in particular by basing payments less on how much therapy someone is getting at home. By law, the new system can’t cost more or less than it otherwise would have, but Medicare reinforced this year that it had “paid more under the new system than it would have under the old system” — and thus continued cuts to home health for next year.

Newsletters

Sign up for STAT Health Care Inc.

Following the flow of money through the health care industry.

Please enter a valid email address. Privacy Policy

NAHC, the home health industry’s lobbying group, said in its lawsuit that Medicare has been violating the requirement to keep things “budget-neutral” and threatens to put home health operators out of business. But one thing NAHC failed to mention: Profits in the home health industry remain near all-time highs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： In areas with more Black doctors, Black people live longer

WSS

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

WATCH: Why do fingernails fall off when they're damaged?

Just how do doctors, lawmakers, and the public define abortion?

NEJM study link tiny plastics in blood vessels to heart problems

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

Colonoscopy at 40? Study finds a possible benefit

knowledge

focus

Sign up for STAT Health Care Inc.

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

WATCH: Why do fingernails fall off when they're damaged?

Hepatitis C has a cure — but many Americans still lack access to it

Death of patient in Alzheimer’s trial raises question of possible risks

Trump demands the U.S. pay no more for drugs than other countries … again

Colonoscopy at 40? Study finds a possible benefit

Medicare details structure of new drug price negotiation program

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Bright Health sells Medicare Advantage business to Molina

With FDA staff opposed to Sarepta therapy, top official intervened

explore

The battle over the Brookhaven Landfill on Long Island

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

Amylyx ALS drug failure raises questions and concerns

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

The Readout: Amylyx, Alumis, and Lundbeck drug updates

focus

hotspot

entertainment

entertainment